by Mark Curtis | Aug 18, 2014
. Welcome to your Update from the Clinic for the month of July. The cancer stem cell companies were back in the news last month. OncoMed initiated its ALPINE clinical trial of Tarextumab for pancreatic cancer, while Stemline Therapeutics announced an investigational...
by Lisa Willemse | Jul 18, 2014
A few months ago, I mentioned that we were involved in the creation of a traveling science exhibit with a number of great partners, and introduced one of the fictional characters, the “Regenerator”, who will be appearing as one of our stem cell...
by Lisa Willemse | Jul 14, 2014
Written with contributions from Geoff Lomax, CIRM’s Senior Officer for Medical and Ethical Standards and Rosario Isasi, Research Associate at McGill University and Academic Secretary for the International Stem Cell Forum Ethics Working Party. Portions of this post...
by Stacey Johnson | Jun 13, 2014
. What’s small and blue and brings a smile to your face? No, not a Smurf and I’m not talking about a little blue pill either. It’s the little cartoon guy from Life Technologies and he has a mission for those who are ISSCR-bound (and even those who aren’t). Watch him...
by Paul Krzyzanowski | Apr 22, 2014
> If you’ve stayed current with the STAP cell fiasco you know it’s been a wild ride. STAP cells, or Stimulus-Triggered Acquisition of Pluripotency cells, caught the imagination of many in late January through their sheer simplicity: You hit cells with a shock of...
Comments